Progyny vs GE HealthCare
Side-by-side comparison of AI visibility scores, market position, and capabilities
Progyny is a fertility and family building benefits management company providing employer-sponsored fertility coverage that improves outcomes and reduces total fertility spend.
About
Progyny is a publicly traded fertility benefits management company founded in 2008 that has become the leading provider of employer-sponsored fertility benefits in the United States. The company manages fertility coverage for self-insured employers, providing access to a national network of top-tier fertility clinics, a proprietary Smart Cycle benefits design that bundles all medically necessary components of a treatment cycle, and dedicated patient care advocates who guide employees through fertility treatment. Progyny went public on Nasdaq in 2019 under the ticker PGNY and serves over 430 employers covering over 6 million lives including many Fortune 500 companies. The company has published clinical outcomes data demonstrating higher live birth rates, lower multiple birth rates, and lower NICU costs compared to traditional indemnity fertility coverage, translating into healthcare cost savings that offset the benefit cost for employers. Progyny's Smart Cycle design bundles medications, lab tests, and procedures into a single benefit unit that eliminates the piecemeal authorization challenges of traditional insurance coverage. The company competes with Carrot Fertility and Kindbody in the employer fertility benefits market.
Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healthineers.
About
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designing, manufacturing, and servicing medical imaging systems, patient monitoring equipment, pharmaceutical diagnostics, and AI-powered clinical decision support software through approximately 51,000 employees in 160 countries. GE HealthCare was spun off from General Electric Company in January 2023 — one of the most significant healthcare demergers in history — and has operated as an independent public company building its own capital structure, R&D investment priorities, and operational identity separate from GE's industrial conglomerate structure. In fiscal year 2024, GE HealthCare reported revenues of approximately $19.7 billion, with its four business segments contributing: Imaging (MRI, CT, X-ray, molecular imaging — ~$9.1B), Ultrasound (~$3.0B), Patient Care Solutions (monitoring, anesthesia — ~$3.6B), and Pharmaceutical Diagnostics (PET/SPECT contrast agents — ~$2.6B). CEO Peter Arduini has prioritized accelerating GE HealthCare's AI integration across its imaging portfolio — the Edison AI platform (100+ AI models cleared or in development for radiology workflows) embeds AI-assisted detection, workflow optimization, and image quality enhancement into GE HealthCare scanners, positioning the company as a digital health platform rather than a hardware manufacturer.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.